文献速递其他结缔组织病

过去五十年年轻人群中系统性硬化症死亡率持续下降

Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

基于美国全国死亡数据库和人口普查数据,分析1968至2015年系统性硬化症(SSc)按年龄的死亡率变化。≤44岁人群SSc年龄标化死亡率从1968年每百万人1.0降至2015年0.4,累计下降60%;≥65岁人群则累计上升187.0%。

要点

  • ≤44岁人群SSc死亡比例年均变化-2.2%,非SSc为-1.5%。
  • ≤44岁人群SSc年龄标化死亡率从1968年1.0降至2015年0.4每百万人。
  • ≥65岁人群SSc年龄标化死亡率累计上升187.0%,年均变化2.0%。

核心结论

  • 过去五十年SSc死亡率在年轻人群中持续下降。
  • ≤44岁人群SSc年龄标化死亡率累计下降60%,年均变化-1.9%。
  • ≥65岁人群SSc年龄标化死亡率累计上升187.0%,年均变化2.0%。

研究设计与样本

  • 基于美国全国死亡数据库和全体美国居民人口普查数据的人群研究。
  • 计算1968至2015年每年SSc与非SSc按年龄的死亡比例及年龄标化死亡率(ASMR)。
  • 采用joinpoint回归估计各参数的平均年度百分比变化(AAPC)。

主要发现

  • 1968至2015年SSc作为根本死因的记录:≤44岁5457例,45-64岁18395例,≥65岁22946例。
  • ≤44岁人群年度死亡比例下降幅度SSc大于非SSc:AAPC -2.2%(95%CI -2.4%至-2.0%)vs -1.5%(-1.9%至-1.1%)。
  • ≤44岁人群SSc-ASMR从1968年每百万人1.0(95%CI 0.8-1.2)降至2015年0.4(0.3-0.5),累计下降60%,AAPC -1.9%(95%CI -2.5%至-1.2%)。
  • ≤44岁人群SSc-ASMR与非SSc-ASMR比值累计下降20%,AAPC -0.3%(95%CI -1.15%至0.55%)。
  • ≥65岁人群SSc-ASMR累计上升187.0%,AAPC 2.0%(95%CI 1.8-2.2);SSc-ASMR与非SSc-ASMR比值累计上升395.4%,AAPC 3.3%(95%CI 2.9-3.7)。

关键数值与推荐

  • ≤44岁人群SSc-ASMR的AAPC为-1.9%(95%CI -2.5%至-1.2%)。
  • ≥65岁人群SSc-ASMR的AAPC为2.0%(95%CI 1.8-2.2)。
  • ≥65岁人群SSc-ASMR与非SSc-ASMR比值的AAPC为3.3%(95%CI 2.9-3.7)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We aimed to assess SSc mortality by age in the general population over the past five decades. METHODS: This is a population-based study using a national mortality database and the census data for all US residents. We calculated the proportions of deaths for SSc and for all other causes (non-SSc) by age, and calculated age-standardized mortality rates (ASMRs) for SSc and non-SSc, and the ratio of SSc-ASMR to non-SSc-ASMR by age groups for each year from 1968 through 2015. We performed joinpoint regression to estimate the average annual percent change (AAPC) for each of these parameters. RESULTS: SSc was recorded as the underlying cause of death in 5457 decedents aged ≤44 years, 18 395 aged 45-64, and 22 946 aged ≥65 from 1968 through 2015. At ages ≤44, the proportion of annual deaths decreased more for SSc than for non-SSc: AAPC, -2.2% (95% CI, -2.4% to -2.0%) for SSc vs -1.5% (-1.9% to -1.1%) for non-SSc. Consistently, SSc-ASMR decreased from 1.0 (95% CI, 0.8-1.2) in 1968 to 0.4 (0.3-0.5) per million persons in 2015, a cumulative decrease of 60% at an AAPC of -1.9% (95% CI, -2.5% to -1.2%) at ages ≤44. The SSc-ASMR:non-SSc-ASMR ratio also decreased [cumulative -20%; AAPC -0.3% (95% CI, -1.15% to 0.55%)] in the ≤44-years group. In contrast, those aged ≥65 experienced a steep increase in the SSc-ASMR [cumulative 187.0%; AAPC 2.0% (95% CI, 1.8-2.2)] and the SSc-ASMR:non-SSc-ASMR ratio [cumulative 395.4%; AAPC 3.3% (95% CI, 2.9-3.7)]. CONCLUSION: Mortality for SSc has steadily decreased at younger ages over the past five decades.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Yen EY, Singh DR, Singh RR, et al. Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades. Rheumatology (Oxford). 2024. PMID: 37216898. doi:10.1093/rheumatology/kead233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。